{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:13:52Z","timestamp":1793121232511,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10637-018-0586-9","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T04:15:26Z","timestamp":1521087326000},"page":"715-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation"],"prefix":"10.1007","volume":"36","author":[{"given":"Midori","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenobu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Moribuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Tokito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"586_CR1","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","volume":"362","author":"M Maemondo","year":"2010","unstructured":"Maemondo M, Inoue A, Kobayashi K et al (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380\u20132388","journal-title":"N Engl J Med"},{"key":"586_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","volume":"11","author":"T Mitsudomi","year":"2009","unstructured":"Mitsudomi T, Morita S, Yatabe Y et al (2009) Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 11:121\u2013128","journal-title":"Lancet Oncol"},{"key":"586_CR3","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/j.1349-7006.2007.00600.x","volume":"98","author":"T Fukui","year":"2007","unstructured":"Fukui T, Tsuta K, Furuta K et al (2007) Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci 98:1714\u20131719","journal-title":"Cancer Sci"},{"key":"586_CR4","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/1078-0432.CCR-08-0332","volume":"14","author":"A Tatematsu","year":"2008","unstructured":"Tatematsu A, Shimizu J, Murakami Y et al (2008) Epidermal growth factor receptor mutations in small cell lung cancer. Clin Cancer Res 14:6092\u20136096","journal-title":"Clin Cancer Res"},{"key":"586_CR5","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3816\/CLC.2010.n.046","volume":"11","author":"N Alam","year":"2010","unstructured":"Alam N, Gustafson KS, Ladanyi M et al (2010) Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with Gefitinib-responsive adenocarcinoma of the lung. Clin Lung Cancer 11:E1\u2013E4","journal-title":"Clin Lung Cancer"},{"key":"586_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/JTO.0b013e3181f94abb","volume":"6","author":"T-H Shiao","year":"2011","unstructured":"Shiao T-H, Chang Y-L, Yu C-J et al (2011) Epidermal growth factor receptor mutations in small cell lung cancer: a brief report. J Thorac Oncol 6:195\u2013198","journal-title":"J Thorac Oncol"},{"key":"586_CR7","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","volume":"378","author":"JP van Meerbeeck","year":"2011","unstructured":"van Meerbeeck JP, Fennell DA, De Ruysscher DKM (2011) Small-cell lung cancer. Lancet Oncol 378:1741\u20131755","journal-title":"Lancet Oncol"},{"key":"586_CR8","first-page":"37","volume":"4","author":"O S-HI","year":"2008","unstructured":"S-HI O, Ziogas A, Zell JA (2008) Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol 4:37\u201343","journal-title":"J Thorac Oncol"},{"key":"586_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.21496","volume":"118","author":"H Shigematsu","year":"2005","unstructured":"Shigematsu H, Gazdar AF (2005) Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 118:257\u2013262","journal-title":"Int J Cancer"},{"key":"586_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lungcan.2016.02.012","volume":"95","author":"BJ Siegele","year":"2016","unstructured":"Siegele BJ, Shilo K, Chao BH et al (2016) Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: two cases and a review of the literature. Lung Cancer 95:65\u201372","journal-title":"Lung Cancer"},{"issue":"6","key":"586_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/JTO.0000000000000142","volume":"9","author":"AM Varghese","year":"2014","unstructured":"Varghese AM, Zakowski MF, Yu HA et al (2014) Small-cell lung cancers in patients who never smoked cigarettes. J Thorac Oncol 9(6):892","journal-title":"J Thorac Oncol"},{"key":"586_CR12","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1200\/JCO.2012.44.2806","volume":"31","author":"LV Sequist","year":"2013","unstructured":"Sequist LV, Yang JC, Yamamoto N et al (2013) Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J Clin Oncol 31:3327\u20133334","journal-title":"J Clin Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-018-0586-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-018-0586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-018-0586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:22:56Z","timestamp":1678558976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-018-0586-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s10637-018-0586-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"18 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the declaration of Helsinki and ethical standards of the institutional and\/or national research committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}